Victor Ling

From Wikipedia, the free encyclopedia

Dr. Victor Ling is an award-winning Canadian researcher in the field of medicine. Ling's research focuses on drug resistance in cancer. He is best known for his discovery of P-glycoprotein, one of the proteins responsible for multidrug resistance.

Ling was born in China, and emigrated to Canada as a child. He received his bachelor's degree in 1966 from the University of Toronto and his PhD in 1969 from the University of British Columbia. In 2006, he was awarded an honorary doctorate from Trinity Western University. He undertook post-doctoral training with nobel-laureate Dr. Fred Sanger at Cambridge University. Ling is currently Assistant Dean of the Faculty of Medicine at the University of British Columbia and Vice-President, Discovery at the BC Cancer Agency in Vancouver, British Columbia.

[edit] Honours

1990, awarded the Gairdner Award from the Gairdner Foundation for outstanding contributions to medical science
1990, received his newborn daughter
1991, awarded the Charles F. Kettering Prize
1991, awarded the Steiner Award, the highest honour in cancer research
1992, received his newborn son
1994, awarded the Robert L. Noble Prize by the National Cancer Institute of Canada
2000, appointed to the Order of British Columbia